Delivery Order SPE2DB22D3011-SPE2DB24FQ3QV
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOOSTRIX TDAP vaccine syringes, a critical pharmaceutical product used to support military and government healthcare programs. The firm-fixed-price delivery order has a ceiling value of $2,554.30 and an ultimate completion date of September 19, 2024. This award is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $1,031.16 and a period of performance through July 1, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) by the Defense Logistics Agency (DLA) is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5mL). The contract, valued at $1,031.16, is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. The contract is not designated with a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Boostrix TDAP vaccine syringes to the Defense Logistics Agency (DLA), a defense agency. The fixed-price, $1,880.83 contract has a performance period ending on June 18, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and...
This federal contract award is for the delivery of Boostrix TDAP vaccine syringes, 0.5mL, to the Defense Logistics Agency (DLA). The contract, valued at $25,492.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccines in 0.5 mL syringes. The contract has a firm fixed price of $2,554.30 and a completion date of May 28, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,862.63, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,062.24, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This appears to be a one-time Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $66,714.57 firm fixed-price delivery order is for the supply of 4,565,698,832 units of the BOOSTRIX TDAP vaccine in 0.5ML syringes. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of Boostrix TDAP vaccine syringes. The $4,224.11 firm-fixed-price delivery order contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies,...